DOP86: Corticosteroid-sparing effects of ustekinumab therapy for Ulcerative Colitis through 3 years: UNIFI long-term extensionECCO'21 VirtualYear: 2021
Authors: Scherl, E.J.(1);Rowbotham, D.S.(2);Danese, S.(3);Sandborn, W.J.(4);Miao, Y.(5);Zhang, H.(5);Abreu, M.T.(6);Panaccione, R.(7);Afif, W.(8);Hisamatsu, T.(9);Leong, R.W.(10);Arasaradnam, R.P.(11);Sands, B.E.(12);Marano, C.(5)
(1)New York Presbyterian Weill Cornell Medical College, Roberts Center for Inflammatory Bowel Disease, New York, United States;(2)Auckland City Hospital, Gastroenterology, Auckland, New Zealand;(3)Instituto Clinico Humanitas, Department of Gastroenterology, Milano, Italy;(4)University of California San Diego, Division of Gastroenterology, La Jolla, United States;(5)Janssen Research & Development- LLC, Immunology, Spring House, United States;(6)University of Miami Miller School of Medicine, Department of Medicine, Miami, United States;(7)University of Calgary, Inflammatory Bowel Disease Unit, Calgary, Canada;(8)McGill University Health Centre, Division of Gastroenterology, Montreal, Canada;(9)Kyorin University School of Medicine, Third Department of Internal Medicine, Tokyo, Japan;(10)Concord Repatriation General Hospital, Inflammatory Bowel Disease Clinic, New South Wales, Australia;(11)University Hospital Coventry and Warwickshire, Gastrointestinal Medicine, Coventry, United Kingdom;(12)Mount Sinai School of Medicine, Henry D. Janowitz Division of Gastroenterology, New York, United States UNIFI
DOP87: Disease clearance as a new therapeutic target in patients with Ulcerative Colitis: A multicenter retrospective cohort studyECCO'21 VirtualYear: 2021
Authors: D'Amico, F.(1);Fiorino, G.(1);Massarini, E.(1);Solitano, V.(1);Guillo, L.(2);Allocca, M.(1);Furfaro, F.(3);Zilli, A.(3);Bonovas, S.(1);Peyrin-Biroulet, L.(4);Danese, S.(5)
(1)Humanitas University, Department of Biomedical Sciences, Milan, Italy;(2)University Hospital of Nancy- Unicersity of Lorraine, Department of Gastroenterology and Inserm NGERE U1256, Vandoeuvre-lès-Nancy, France;(3)Humanitas Research Hospital- IRCCS, IBD center, Milan, Italy;(4)University Hospital of Nancy- University of Lorraine, Department of Gastroenterology and Inserm NGERE U1256, Vandoeuvre-lès-Nancy, France;(5)IRCCS Humanitas Research Hospital, Department of Gastroenterology, Rozzano, Italy
DOP88: Effect of risankizumab on patient-reported outcomes in patients with Crohn’s Disease who had an inadequate response or intolerance to conventional and/or biologic treatments: Results from phase 3 MOTIVATE and ADVANCE trialsECCO'21 VirtualYear: 2021
Authors: Peyrin-Biroulet, L.(1);Louis, E.(2);Ghosh, S.(3);Lee, S.D.(4);Griffith, J.(5);Wallace, K.(5);Berg, S.(5);Loftus Jr, E.V.(6)
(1)University Hospital of Nancy- Lorraine University, Gastroenterology, Vandoeuvre, France;(2)University Hospital CHU of Liège, Gastroenterology, Liège, Belgium;(3)University of Birmingham, Institute of Translational Medicine, Birmingham, United Kingdom;(4)University of Washington, Department of Medicine- Division of Gastroenterology, Seattle, United States;(5)AbbVie Inc., Health Economics and Outcomes Research, North Chicago, United States;(6)Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, United States
DOP89: Effects of ferric derisomaltose and ferric carboxymaltose on hypophosphatemia in iron-deficiency anaemia due to Inflammatory Bowel Disease: A Phase IV randomised clinical trialECCO'21 VirtualYear: 2021
Authors: Zoller, H.(1);Wolf, M.(2);Blumenstein, I.(3);Primas, C.(4);Lindgren, S.(5);Thomsen, L.L.(6);Reinisch, W.(4);Iqbal, T.(7)
(1)Medical University of Innsbruck, Christian Doppler Laboratory of Iron and Phosphate Biology- Department of Medicine I, Innsbruck, Austria;(2)Duke University School of Medicine, Medicine – Nephrology, Durham- NC, United States;(3)University Hospital Frankfurt, Department of Internal Medicine 1, Frankfurt, Germany;(4)Medical University of Vienna, Department of Internal Medicine III, Vienna, Austria;(5)Clinical Sciences Malmö- Lund University- Sweden, Gastroenterology- Skane University Hospital, Lund, Sweden;(6)Pharmacosmos A/S, Clinical Research & Development, Holbæk, Denmark;(7)Queen Elizabeth Hospital Birmingham, Department of Gastroenterology, Birmingham, United Kingdom
DOP90: Physician global assessment of IBD Activity is associated with COVID-19 severity in patients aged less than 50 yearsECCO'21 VirtualYear: 2021
Authors: Ricciuto, A.(1);Lamb, C.(2,3);Benchimol, E.I.(1);Walker, G.(4);Kennedy, N.(5,6);Kuenzig, M.E.(1);Kaplan, G.(7);Griffiths, A.M.(1);Reinisch, W.(8);Sebastian, S.(9,10)
(1)The Hospital for Sick Children, Division of Gastroenterology Hepatology and Nutrition, Toronto, Canada;(2)Newcastle University, Gastroenterology, Newcastle upon Tyne, United Kingdom;(3)Newcastle Upon Tyne Hospitals NHS Foundation Trust, Gastroenterology, Newcastle upon Tyne, United Kingdom;(4)Torbay and South Devon NHS Foundation Trust, Gastroenterology, Torbay, United Kingdom;(5)University of Exeter, Gastroenterology, Exeter, United Kingdom;(6)Royal Devon and Exeter NHS Foundation Trust, Gastroenterology, Exeter, United Kingdom;(7)University of Calgary, Gastroenterology, Calgary, Canada;(8)Medical University of Vienna, Gastroenterology, Vienna, Austria;(9)University of Hull, Gastroenterology, Kingston upon Hull, United Kingdom;(10)Hull University Teaching Hospitals NHS Trust, Gastroenterology, Kingston Upon Hull, United Kingdom
N01: Does physical activity positively impact fatigue in individuals with Inflammatory Bowel Disease?ECCO'21 VirtualYear: 2021
Authors: Farrell, D.(1);Bager, P.(2);Bredin, F.(3);Cairnes, V.(4);Forry, M.(5);Gilham, E.(3);Godwin, N.(5);Herdmangrant, R.(6);Ni Dhalaigh, D.(1);O' Shea, T.(7);Sugrue, K.(8);
(1)Munster Technological University, Department of Nursing and Healthcare Sciences, Tralee, Ireland;(2)Aarhus University Hospital, Department of Clinical Medicine - The Department of Hepatology and Gastroenterology, Aarhus, Denmark;(3)The Queen Elizabeth Hospital- NHS Foundation Trust, Department of Gastroenterology, Kings Lynn, United Kingdom;(4)Royal Devon and Exeter NHS Foundation Trust, Department of Gastroenterology, Exeter, United Kingdom;(5)Beaumont Hospital, Department of Gastroenterology, Dublin, Ireland;(6)Kingston Hospital NHS Foundation Trust, Research and Innovation Department, Kingston upon Thames, United Kingdom;(7)Munster Technological University, Department of Business, Tralee, Ireland;(8)Mercy University Hospital, Department of Gastroenterology, Cork, Ireland
N03: Information flow experiences during COVID-19 in IBD patients: a prospective observational studyECCO'21 VirtualYear: 2021
Authors: Geens, P.(1);De Dycker, E.(1);Paps, A.(1);Lambrechts, T.(1);Sabino, J.(1);Ferrante, M.(1);Vermeire, S.(1);
(1)KU Leuven, gastro enterology, Leuven, Belgium
N04: Being an IBD Clinical Nurse Specialist in the UK National Health Service: Challenges, Stressors and Coping MechanismsECCO'21 VirtualYear: 2021
Authors: Dibley, L.(1);Kemp, K.(2);Duncan, J.(3);Mason, I.(4);Lisa, Y.(5);
(1)University of Greenwich, Faculty of Education- Health and Human Sciences, London, United Kingdom;(2)Manchester Royal Infirmary, Department of Gastroenterology, Manchester, United Kingdom;(3)Takeda, Nurse Education, London, United Kingdom;(4)Royal Free London NHS Foundation Trust, Department of Gastroenterology, London, United Kingdom;(5)London North West University Healthcare NHS Trust, St Mark's Hospital- IBD Unit, London, United Kingdom
N05: A Systematic Review of Self-Management Intervention Study for Patients with Inflammatory Bowel DiseaseECCO'21 VirtualYear: 2021
Authors: Lizawa, M.(1);Hirose, L.(1);Tairaka, A.(1);Maya, N.(2);
(1)Takeda Pharmaceutical Company Limited., Japan Medical Office, Tokyo, Japan;(2)Mukogawa Women’s University, School of Nursing, Hyogo, Japan
N06: Patient perspectives on the role of the IBD nurse and telemedicine during COVID-19 pandemic: results from a Belgian tertiary IBD unitECCO'21 VirtualYear: 2021
Authors: Dewitte, G.(1);Geldof, J.(1,2);Truyens, M.(1,2);Lobaton, T.(1,2);
(1)UZ Gent, Gastro-enterology, Gent, Belgium;(2)Ghent University, IBD research unit – Gastroenterology- Department of Internal Medicine and Pediatrics, Ghent, Belgium
N07: a qualitative study of the impact of inflammatory bowel disease on partnersECCO'21 VirtualYear: 2021
Authors: Thapwong, P.(1);Norton, C.(2);Terry, H.(3);Czuber-Dochan, W.(4);
(1)King's college London, Nursing faculty, London, United Kingdom;(2)King's college London, Nursing faculty- Adult nursing department, London, United Kingdom;(3)Crohn's and Colitis UK, Policy- Public Affairs and Research, London, United Kingdom;(4)King's college London, Nursing faculty- Adult nursing, London, United Kingdom
N08: Construction of an explanatory model for quality of life in outpatients with ulcerative colitisECCO'21 VirtualYear: 2021
Authors: Takahashi, M.(1);Nunotani, M.(2);Aoyama, N.(3);
(1)Mukogawa Women’s University- Graduate School of Nursing, Department of nursing, Nishinomiya, Japan;(2)Mukogawa Women’s University, Department of nursing, Nishinomiya, Japan;(3)Aoyama Medical Clinic, Gastroenterologist, Kobe, Japan
N09: Sexuality as lived incompleteness: exploring intimacy and sexuality experiences of people living with inflammatory bowel diseaseECCO'21 VirtualYear: 2021
Authors: Fourie, S.(1,2);Norton , C.(2);Jackson, D.(3);Czuber-Dochan , W.(2);
(1)University of Oxford, Nuffield Department of Medicine, Oxford, United Kingdom;(2)King's College London, Florence Nightingale Faculty of Nursing Midwifery and Palliative Care, London, United Kingdom;(3)University of Sydney, Nursing, Sydney, Australia; Simmons Group
N10: Experience with telemedicine during the COVID-19 pandemic and preferences for future e-health in a large IBD cohortECCO'21 VirtualYear: 2021
Authors: Breiteneicher, S.(1);Le Thi, T.G.(2);Klucker, E.(2);Schwerd, T.(2);Csollarova, K.(1);Neuhaus, L.(1);Koletzko, S.(2);Török, H.(1);Koletzko, L.(1);
(1)LMU Klinikum Campus Großhadern, Medizinische Klinik und Poliklinik II, Munich, Germany;(2)Dr. von Hauner Children’s Hospital- LMU Klinikum, Department of Pediatrics, Munich, Germany
N11: Complementary and alternative methods to improve quality of life in patients with inflammatory bowel diseases: a systematic literature reviewECCO'21 VirtualYear: 2021
Authors: Martinato, M.(1);Comoretto, R.I.(1);Zampieri, A.(1);Monaco, E.(1);Barberio, B.(2);Azzolina, D.(1);Savarino, E.(2);Gregori, D.(1);
(1)University of Padova, Department of Cardiac-Thoracic-Vascular Sciences and Public Health, Padova, Italy;(2)University of Padova, Department of Surgical Oncological and Gastroenterological Sciences, Padova, Italy; Nursing Research Laboratory
N12: A decade of waiting to know is not good enough! Experiences of women with vulval Crohn’s diseaseECCO'21 VirtualYear: 2021
Authors: Fourie, S.(1,2);Czuber-Dochan, W.(2);Jackson, D.(3);Norton, C.(2);
(1)University of Oxford, Nuffield Department of Medicine, Oxford, United Kingdom;(2)King's College London, Florence Nightingale Faculty of Nursing Midwifery and Palliative Care, London, United Kingdom;(3)University of Sydney, Faculty of Medicine and Health, Sydney, Australia
N13: Living in rural communities with Inflammatory Bowel Disease: Perspectives on healthcare use and access to care from patients and providers in one Canadian provinceECCO'21 VirtualYear: 2021
Authors: Rohatinsky, N.(1);Russell, B.(1);Boyd, I.(2);Dickson, A.(3);Fowler, S.(4);Peña-Sánchez, J.N.(5);Quintin, C.L.(6);Risling, T.(1);Wicks, K.(7);Wicks, M.(7);
(1)University of Saskatchewan, College of Nursing, Saskatoon, Canada;(2)University of Saskatchewan, College of Nursing, Kinistino, Canada;(3)Saskatchewan Health Authority, Chronic Disease Management, Saskatoon, Canada;(4)University of Saskatchewan, College of Medicine- Gastroenterology and Hepatology, Saskatoon, Canada;(5)University of Saskatchewan, College of Medicine- Community Health and Epidemiology, Saskatoon, Canada;(6)Crohn’s and Colitis Canada, Saskatchewan, Saskatoon, Canada;(7)University of Saskatchewan, College of Nursing, Cabri, Canada
